Compare Royalty Pharma (RPRXN) vs. Competitors

1 Followers

Comparison Results

RPRXN

Royalty Pharma

$1049.21

$596.94B

23.71

54.30%

7 Buy

0 Hold

0 Sell

Strong Buy

Corcept Therapeutics

$123.57

$12.56B

223.52

35.97%

4 Buy

0 Hold

1 Sell

Moderate Buy

Prestige Consumer Healthcare

$51.21

$2.14B

12.61

-27.98%

2 Buy

0 Hold

0 Sell

Moderate Buy

Sinovac Biotech

$6.47

$460.27M

-7.80

0.00%

―

Kiniksa Pharmaceuticals

$80.20

$5.91B

70.83

102.27%

7 Buy

0 Hold

0 Sell

Strong Buy

Liquidia Technologies

$70.49

$2.56B

18.25

30.78%

4 Buy

4 Hold

0 Sell

Moderate Buy

xxxxxxxxxxxxx

RPRXN vs LQDA

xxxxxxxxxxxxx

Performance Comparison

MX:RPRXN

Royalty Pharma

1,049.21

392.16

59.68%

CORT

Corcept Therapeutics

116.23

26.38

29.36%

PBH

Prestige Consumer Healthcare

45.26

-17.93

-28.37%

SVA

Sinovac Biotech

6.47

0.00

0.00%

KNSA

Kiniksa Pharmaceuticals

75.79

37.50

97.94%

LQDA

Liquidia Technologies

28.64

5.78

25.28%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >